We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$347B
AUM Growth
+$49B
Cap. Flow
+$12.7B
Cap. Flow %
3.67%
Top 10 Hldgs %
25.82%
Holding
11,328
New
1,232
Increased
3,827
Reduced
4,449
Closed
1,709

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$1.33B
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$781M
3
TSLA icon
Tesla
TSLA
+$468M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$467M
5
HD icon
Home Depot
HD
+$344M

Sector Composition

Rank Sector Weight
1 Technology 2.2%
2 Consumer Discretionary 1.94%
3 Communication Services 1.89%
4 Healthcare 1.12%
5 Financials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDR
9451
DELISTED
Blonder Tongue Laboratories Inc
BDR
$18K ﹤0.01%
23,564
+7,784
+49% +$5.31K
NBRV
9452
CALL
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$18K ﹤0.01%
53
-5
-9% -$2.29K
GROW icon
9453
CALL
US Global Investors
GROW
$40.9M
$17K ﹤0.01%
11,500
-37,000
-76% -$59.6K
HSDT icon
9454
Solana Company
HSDT
$129M
0
TBHC
9455
DELISTED
The Brand House Collective
TBHC
$17K ﹤0.01%
13,639
-19,009
-58% -$25.4K
VIRX
9456
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$17K ﹤0.01%
1,403
-684
-33% -$11.5K
ASAP
9457
CALL
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$17K ﹤0.01%
2,565
-1,975
-44% -$21.9K
MLNT
9458
PUT
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$17K ﹤0.01%
31,300
-158,500
-84% -$384K
INOD icon
9459
Innodata
INOD
$1.97B
$16K ﹤0.01%
+14,156
New +$18.1K
SOL
9460
DELISTED
Emeren Group
SOL
$16K ﹤0.01%
11,199
-49,148
-81% -$73K
ONIT
9461
CALL
Onity Group
ONIT
$294M
$16K ﹤0.01%
780
-687
-47% -$16.6K
YTEN
9462
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$16K ﹤0.01%
+97
New +$30.8K
TDW.WS.B
9463
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$16K ﹤0.01%
13,857
-5,324
-28% -$5.51K
BLCM
9464
PUT
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$16K ﹤0.01%
1,260
+160
+15% +$1.48K
DTEA
9465
PUT
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$16K ﹤0.01%
+10,700
New +$17.9K
BLNKW
9466
DELISTED
Blink Charging Co. Warrant
BLNKW
$16K ﹤0.01%
36,305
-3,614
-9% -$1.19K
NEOS
9467
PUT
DELISTED
Neos Therapeutics, Inc
NEOS
$16K ﹤0.01%
+10,800
New +$16.2K
PER
9468
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$16K ﹤0.01%
+18,988
New +$24.4K
NEBUW
9469
DELISTED
Nebula Acquisition Corporation Warrant
NEBUW
$16K ﹤0.01%
+12,605
New +$12.5K
CNET icon
9470
PUT
ZW Data Action Technologies
CNET
$5.17M
$15K ﹤0.01%
+630
New +$15.7K
HTGM
9471
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$15K ﹤0.01%
+117
New +$15.8K
CBL
9472
CALL
DELISTED
CBL& Associates Properties, Inc.
CBL
$15K ﹤0.01%
14,500
-45,000
-76% -$58.9K
PSV
9473
DELISTED
Hermitage Offshore Services Ltd.
PSV
$15K ﹤0.01%
+14,973
New +$16.3K
HCR
9474
DELISTED
Hi-Crush Inc. Common Stock
HCR
$15K ﹤0.01%
16,859
-289,099
-94% -$305K
DXLG icon
9475
Destination XL Group
DXLG
$34.3M
$14K ﹤0.01%
+11,011
New +$15.5K

Similar funds

Jeff Yass's Q4 2019 Portfolio in Review

As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass deployed $12.7B of net new capital in Q4 2019, opening 1,232 new positions and adding to 3,827 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Amazon, an estimated $1.36B trimmed.

  • Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
  • Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
  • Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
  • Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
  • Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
  • Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
  • Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.